Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00731666
Other study ID # US001SU
Secondary ID
Status Completed
Phase N/A
First received August 7, 2008
Last updated September 27, 2013
Start date December 2007
Est. completion date May 2011

Study information

Verified date September 2013
Source Coloplast A/S
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study is designed to assess the effectiveness of the Coloplast Titan® Inflatable Penile Prosthesis (IPP) at maintaining or increasing penile length after implantation of the device. It will incorporate a modified method of cylinder sizing during implantation and a max-inflate technique after implantation.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 2011
Est. primary completion date May 2010
Accepts healthy volunteers No
Gender Male
Age group 25 Years to 75 Years
Eligibility Inclusion Criteria:

- Has an estimated life expectancy of more than 5 years

- Has been diagnosed with erectile dysfunction

- Is willing to have the Titan IPP implanted

- Is able and willing to complete all follow-up visits and procedures indicated in this protocol

- Has been informed of the nature of the study and agrees to its provisions and - Has provided written informed consent as approved by the Institutional Review board of the respective site

Exclusion Criteria:

- Participant has had a previous penile prosthesis or prior penile enlargement surgeries

- Participant has a compromised immune system

- Participant has had a myocardial infarction or coronary artery stent placement within 2 months prior to treatment

- Participant does not have manual dexterity or mental ability to operate the pump

- Participant has an active urogenital infection or active skin infection in region of surgery

- Participant is diagnosed with fibrotic disease, such as priapism or Peyronie's disease

- Participant is diagnosed with Chordee

- Participant has neuropathy

- Participant has a serious bleeding disorder or coagulopathy

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Inflatable Penile Prosthesis
Hydraulic system designed to be surgically implanted into the penis for the management of erectile dysfunction. The implant provides the participant with voluntary control over the erect and flaccid states of the penis.

Locations

Country Name City State
United States University of Texas Health Science Center at Houston Houston Texas
United States Regional Urology, LLC Shreveport Louisiana
United States James A Haley VA Tampa Florida

Sponsors (1)

Lead Sponsor Collaborator
Coloplast A/S

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Study's Primary Objective Will Assess the Change in Penile Length. 12 months No
Secondary Assess Participant Satisfaction With the Penile Length at Baseline, 12 and 24 Months Post Implantation Via Participant Questionaire. 12 and 24 months No
Secondary The Rate of Change in Male Stress Urinary Incontinence(SUI). Subject responses to 3 questions were evaluated:
On average, how many of these (pads, tissues, disposable undergarments) would you use to protect against wetness during the day?
Overall, how often have you needed to change your daily activities because of urinary incontinence?
Overall, how big of a social problem has urinary incontinence been for you during the past month?
12 months No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05366504 - LiST Plus PRP Injection Therapy vs LiST Monotherapy for ED Treatment Phase 2/Phase 3
Recruiting NCT02745808 - Injectable Collagen Scaffold™ Combined With HUC-MSCs for the Improvement of Erectile Function in Men With Diabetes Phase 1
Recruiting NCT02573805 - the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males N/A
Withdrawn NCT01967251 - Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction Phase 2
Withdrawn NCT02579148 - Collagen Scaffolds Loaded With HUCMSCs for the Improvement of Erectile Function in Men With Diabetes Phase 1
Recruiting NCT02225548 - Sagene 2014 - Parkinson's Disease and Erectile Dysfunction Phase 4
Completed NCT02587988 - Trial to Evaluate the Efficacy and Safety of HCP1302 Phase 3
Completed NCT02945462 - Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED) Phase 1
Completed NCT01937871 - A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) Phase 3
Completed NCT01698684 - Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction Phase 4
Not yet recruiting NCT01321489 - A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies Phase 3
Terminated NCT01262833 - Pudendal Assessment in Erectile Dysfunction N/A
Completed NCT01230541 - Effect of Udenafil on Spermatogenesis Phase 1
Completed NCT02226237 - Effectiveness of Physiotherapy to Treat the Urinary Incontinence and Erectile Dysfunction Post Retropubic Prostatectomy N/A
Completed NCT01037218 - Treatment of Erectile Dysfunction II Phase 3
Completed NCT01037244 - Treatment of Erectile Dysfunction I Phase 3
Recruiting NCT00313898 - Effect of Sildenafil on Quality of Sexual Life in Mild to Normally Sexually Functioning Males Phase 4
Completed NCT00667979 - Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse Phase 4
Completed NCT00663728 - Assessment of Duration of Erection With Vardenafil 10 mg Phase 4
Completed NCT00421083 - Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury Phase 3